Harry Clifford

Harry Clifford is the product lead for genomics at NVIDIA, using NVIDIA’s expertise in AI, high-performance computing and data analytics stacks to address genomics workflows with accelerated high-accuracy solutions. His background is in bioinformatics and functional genomics, including a PhD from the University of Oxford, postdoctoral experience in the biopharma industry and at the University of Cambridge and entrepreneurial experience in biotech. Harry was listed in Forbes’ 30 Under 30 after cofounding precision oncology company CCG.ai (acquired by Dante Labs), a Y Combinator and Merck Accelerator-backed startup delivering decision support via deep learning and advanced analytical software.

To Save Lives, and Energy, Wellcome Sanger Institute Speeds Cancer Research With NVIDIA Accelerated Computing

The Wellcome Sanger Institute, a key contributor to the international Human Genome Project, is turning to NVIDIA accelerated computing to save energy while saving lives. With one of the world’s… Read Article